New Technologies Applied to the Study of Biological Nanomachines
(R&D Programs in Technology. Reference: S2018 / NMT-4443)
Tec4Bio consolidates a unique consortium in Madrid of engineers, physicists and biologists who develop and apply new biophysical technologies to study key questions in cardiovascular disease and in the organization and replication of DNA.
Developed in two thematic blocks
-
Instrumental and methodological developments in nanoscience applied to mechanobiology.
-
Application of the new tools developed to relevant biological problems with biomedical applications.
goals
GOALS
1. Instrumental development and new methodologies in molecular mechanobiology.
Plus Development of new technologies for manipulating individual molecules in order to study at the molecular level how the force, in combination with other variables, affects the activity of proteins involved in repair processes, DNA maintenance and organization.
2. Instrumental development in cellular mechanobiology.
PlusThe mechanical properties of cells are emerging biomarkers of the cellular state. In order to measure accurately, systematic and automated these properties, the development of new strategies is necessary.
3. New methodologies in molecular mechanobiology.
PlusThe forces that determine the conformation or interactions of a protein can be modulated by post-translational modifications, changes in the chemical environment or, even, due to intrinsic structural changes. To characterize these determining factors, we need the development of new methodologies at the molecular level.
4. New methodologies in cellular and tissue mechanobiology.
PlusHere we develop various complementary methodologies on cell mechanics: rheology and deformability.
5. New technologies for the study of telomere maintenance.
PlusTelomeres are structures that protect the ends of chromosomes and their incorrect homeostasis establishes a causal relationship with cell aging and cancer.. Several macromolecular complexes are involved in its maintenance, this goal aim to focus on molecular characterization, structural and functional of the CST complex (CTC1-STN1-TEN1).
6. New technologies for DNA repair study.
PlusDefects in DNA damage repair systems are responsible for tumor development. Thus, proteins involved in DNA repair are good candidates for the development of new therapies. One of the main repair systems is that of “non-homologous end junction (NHEJ)”, of which a third component has recently been discovered: LINP1, that appears overexpressed in triple negative breast cancers. This objective aims to provide a comprehensive vision (structural, molecular and dynamic) the role of LINP1 in the NHEJ repair system.
7. Study of atherosclerosis as a mechanical disease.
PlusWe will explore in depth the molecular and ultrastructural characteristics of areas prone to atherosclerosis (ZPA) and we will characterize its mechanotransducer mechanisms. These studies will provide new concepts for better prevention., determine the origin of individual variability in the development of the disease, develop new diagnostic evaluation tools and explore new therapeutic pathways.
8. Emerging mechanical properties of proteins as triggers for cardiomyopathies
PlusMost of the mutations that cause hypertrophic cardiomyopathy (MCH) affect sarcomere genes, the contractile mechanical unit of cardiomyocytes. Mutations in the MYBPC3 gene are behind half of HCM cases. Here, We will tackle a multiscale and interdisciplinary study of the mechanisms by which mutations in this gene lead to the development of HCM..
Groups
PARTICIPATING GROUPS
Coordinator and group leader
Fernando Moreno-Herrero
Members
Clara Aicart Ramos
Silvia Hormeño Torres
Francisco Balaguer Pérez
Mikel Marín Baquero
Sara de Bragança Vieira
Ania Dobieżyńska
Eva Martin Cuevas
Ana García del Arco
Maria Teresa Arranz Sarmiento
Group leader
Ricardo García García
Members
Víctor García Gisbert
Simone Benaglia
Francisco Miguel Espinosa Barea
Ruben Miguez Laundry
Juan García Sánchez
Diana Mendez-Arvelo
Group leader
Gustavo Ramón Plaza Baonza
Members
Blanca de los Reyes González Bermúdez
José Pérez Rigueiro
Pigeon Lozano Picazo
Rafael Daza García
Aldo Abarca Ortega
Daniel Corregidor Ortiz
Rachel Tabraue Rubio
Cristina Diaz Alcaraz
Augusto Luis Bruno
Maria Garvia Rodriguez
Nahla Jemni Damer
Group leader
Miguel Ángel del Pozo Barriuso
Members
Asier Echarri Aguirre
Miguel Sánchez Álvarez
Fidel Nicolas Lolo Romero
Giulio Fulgoni
Victor Jiménez Jiménez
María del Carmen Manuela Aboy Pardal
Marta Pulgarín Alfaro
Laura Sotodosos Alonso
Group leader
Jorge Alegre Cebollada
Members
Elías Herrero Galán
Carla Huerta López
Carmen Suay Corredera
Diana Carmen Velázquez Carreras
Agata bak
Inés Martínez Martín
Laura Sen Martin
Manuel Antonio Oria Muriel
Andra Dumitru
Sara Martin Colomo
Group leader
Oscar A. Llorca Blanco
Members
Javier Coloma Cervera
Andrés López Perrote
Ángel Rivera Calzada
Marina Serna Gil
María Ibarra Dauden
Ana González Corpas
Ana Isabel Hernández
Natalia Cuervo
Nayim González Rodríguez
News
NEWS AND EVENTS
Possibilities of using T-cell biophysical biomarkers of aging
Aging is accompanied by T-cell stiffening and reduced interstitial migration through dysfunctional nuclear organization
Strategies for the Biofunctionalization of Straining Flow Spinning Regenerated Bombyx mori Fibers
Publications
PUBLICATIONS
- Publications
- Thesis
Most recent publications:
COLLABORATORS
Collaborators
- Epicardium Development Group and its role in Regeneration (Prof. Dr. Nadia Mercader Huber, CNIC & University of Bern)
- Tumor Biophysics Group (Dr. Miguel Vicente Manzanares, IBMCC-CSIC)
- Genomic Integrity and Structural Biology Group. (Dr. Rafael Fernández Leiro, CNIO)
- Cellular and Molecular Mechanobiology Group (Dr. Pere Roca-Cusachs, IBEC)
- Cellular and Tissue Dynamics Group (Dr. Xavier Trepat, IBEC)
- Grupo de Mechanics of soft and living interfaces (Dr. Marino Arroyo)
- Research Group on non-coding RNAs in hepatocarcinoma and other liver diseases (Dr. Puri Fortes, CIMA)
job
JOB VACANCIES
Positon
Location
Group
Date
Carlos III National Cardiovascular Research Center, CNIC (Madrid)
Dr. Jorge Alegre (MOLMECH_CNIC)
15/03/2021
Carlos III National Cardiovascular Research Center, CNIC (Madrid)
Dr. Miguel Ángel del Pozo (MecanoCaveoLab)
20/02/2021
Biomedical Technology Center, CTB (UPM, Madrid, Campus de Montegancedo)
Dr. Gustavo Plaza (GMB-UPM)
14/02/2021
Biomedical Technology Center, CTB (UPM, Madrid, Campus de Montegancedo)
Dr. Gustavo Plaza (GMB-UPM)
28/12/2020
Biomedical Technology Center, CTB (UPM, Madrid, Campus de Montegancedo)
Dr. Gustavo Plaza (GMB-UPM)
23/12/2020
Postdoctoral Investigator
Carlos III National Cardiovascular Research Center, CNIC (Madrid)
Dr. Miguel Ángel del Pozo (MecanoCaveoLab)
31/12/2020
Biomedical Technology Center, CTB (UPM, Madrid, Campus de Montegancedo)
Dr. Gustavo Plaza (GMB-UPM)
02/01/2020
Carlos III National Cardiovascular Research Center, CNIC (Madrid)
Dr. Miguel Ángel del Pozo (MecanoCaveoLab)
02/12/2019
CNB-CSIC (Madrid, Campus Cantoblanco)
Dr. Fernando Moreno-Herrero (SM-Biophys)
20/09/2019
Carlos III National Cardiovascular Research Center, CNIC (Madrid)
Dr. Jorge Alegre (MOLMECH_CNIC)
24/10/2019